GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AXL, BCL2, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
7.6977 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, MET, PPARA |
7.13053 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2 |
6.7638 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
6.7638 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
6.7638 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.7638 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
6.50247 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SLC6A4, SRC, TYR |
6.2291 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SLC6A4, SRC, TYR |
6.2291 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, RORC, SLC6A4, SRC, TYR |
6.1892 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
6.17931 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
5.65291 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KCNH2, KDR, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, XDH |
5.51974 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC, TERT |
5.51974 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SRC, TERT |
5.40829 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX5, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TYR |
5.31936 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
5.24709 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR, XDH |
5.24709 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.10717 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SLC6A4, SRC |
4.99762 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.98356 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
4.97506 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.93138 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
4.90852 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.90852 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.90852 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.9058 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.9058 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.88882 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, SLC6A4, SRC |
4.82219 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.80109 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.80109 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.70863 |
[BP] GO:0014070 |
response to organic cyclic compound
|
BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, RORC, SLC6A4, SRC, TYR |
4.67443 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.67198 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.60966 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
4.59756 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
4.5563 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.51195 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
4.45576 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A4, SRC, TERT, TYR |
4.39024 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7 |
4.34416 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MET, PPARA |
4.20694 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.11316 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.08947 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.0298 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
3.9911 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.9878 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT |
3.97831 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.94311 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, PTPN1, RORC, SLC6A4, SRC, TERT |
3.93227 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.93227 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.92895 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
3.92895 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
3.90406 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SLC6A4, SRC |
3.8795 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.86456 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.85793 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.85793 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
3.85144 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
3.83788 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.71585 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
3.66202 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.6592 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.65008 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.65008 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.64164 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
3.6081 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.6081 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
3.57787 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.55828 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.55275 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
3.51871 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.48708 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.43501 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
3.42715 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.30656 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7 |
3.27971 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.23889 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.21743 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.18452 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, FABP3, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
3.18245 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.17733 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.15819 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.08235 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.07051 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
3.05877 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.02463 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, PPARA, RORC, SRC |
3.01961 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
3.00449 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, BCL2, CYP19A1, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.00449 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.94209 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.94209 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.91749 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91749 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, KCNH2, MMP12, SLC6A4, SRC, TERT |
2.90446 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.89856 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.86902 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, FLT3, KDR, MET, PTPN1, SRC, XDH |
2.85884 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.79646 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.79646 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.79024 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.79024 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.79024 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT, TYR |
2.77098 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.76532 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.69735 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, TYR |
2.69205 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.66745 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.59727 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
2.59272 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.58565 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CA7, CYP19A1, KCNH2, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.57741 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.5557 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53433 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53433 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.53433 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.52862 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.52813 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.52813 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, TERT |
2.52813 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, ESR1, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
2.52498 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.50737 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, KCNH2, KDR, MET, MMP12, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
2.46943 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.45068 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.45068 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, RORC, SLC6A4, SRC |
2.44733 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.44733 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.44733 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.44733 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.44733 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.41622 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41101 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.37155 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.36759 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, KCNH2, MET |
2.36759 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.36728 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36728 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.36728 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.36234 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, KDR, SRC |
2.36234 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, KCNH2, MMP9 |
2.34861 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.34073 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
2.34073 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
2.32762 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.31919 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.31919 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.31552 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.31124 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.31124 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.31124 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SLC6A4, SRC |
2.28921 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.24779 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, BCL2, CDC25B, ESRRB, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.23427 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.20715 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.18825 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.15207 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15207 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.13111 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.13111 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.11657 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.09879 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.0968 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.07138 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07099 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.06212 |
[BP] GO:0010907 |
None
|
ESRRB, PPARA, SRC |
2.02355 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, PTPN1, SRC |
2.00231 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.00231 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.00231 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A4 |
2.00231 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A4 |
2.00231 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A4 |
2.00231 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A4 |
2.00231 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19 |
2.00231 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KCNH2, KDR, SRC |
2.00231 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2 |
2.00231 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00231 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, KDR, PTPN1, XDH |
1.82764 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KCNH2, KDR, MMP2, MMP9, PIM1, PTPN1, SLC6A4, SRC, TERT, TYR, XDH |
1.52046 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, HSD17B2, PTPN1 |
1.45335 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, AXL, CA12, CA14, CA2, CA4, CSNK2A1, ESR1, FLT3, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
1.38042 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
13.1296 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
7.56809 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TYR, XDH |
6.7638 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7 |
6.2291 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
5.5664 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.42589 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.42589 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.40829 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.0977 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.06681 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.05937 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
4.80935 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
4.67198 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.35027 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
4.31574 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.30912 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
4.12922 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.93258 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.92539 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, SLC6A4, TERT, TYR, XDH |
3.76036 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.75577 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.75577 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.55828 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
3.48498 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.4312 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.42715 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.40706 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
3.35789 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.33092 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.15819 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, SRC, XDH |
3.03321 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.98455 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91749 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.87153 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.84122 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.82304 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.79024 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.77556 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.69205 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.54185 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.53433 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.53433 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.42608 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.34073 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.31919 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.31919 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, FLT3, KCNH2, SLC6A4, TERT, TYR, XDH |
2.31479 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TERT |
2.1546 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13111 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.09597 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.07338 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, BCL2, FLT3, KCNH2, SLC6A4, TERT, TYR, XDH |
2.00231 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19 |
2.00231 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A4 |
2.00231 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.00231 |